Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.
Full description
Shoulder pain thought to be caused by blood and amniotic fluid irritation of the diaphragm and nerves that supply the shoulder, can occur during and/or after a cesarean. Investigators will consent 100 patients, and will enroll 10 patients who develop ISP and have a score of is >5/10 on the Verbal Analog pain Scale (VAS). Patients will be their own controls. Transnasal SPG block will be performed after childbirth, and and beginning at 20 minutes post treatment, the patient will be asked to rate their shoulder pain using the VAS a number of times.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Cesarean
- Presence of post-operative ISP, VAS >5/10
- American Society of Anesthesiologists Class 1 - 3.
- No allergy to lidocaine
Exclusion criteria
- American Society of Anesthesiologists Class 4 or 5.
- Allergy to lidocaine
- Nasal pathology (e.g., deviated septum)
- Patients who receive sedatives during cesarean
- Bleeding diathesis
- Any patient who the PI feels will be unable to comply with all protocol related procedures
- Shoulder pain prior to cesarean
Trial design
Primary purpose
Allocation
Interventional model
Masking
117 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal